CooperVision (COO): Debts to Book Capitalization

Corporate company logo of CooperVision (COO)

As a leader in ophthalmology and women's health, does The Cooper Companies (COO) maintain financial stability? Examining the total debt-to-equity ratio on GURU.Markets, we see that the 0.33 level serves as a critical benchmark. Growth is driven by MiSight lenses and expansion in Asia, while operational flexibility is maintained through effective collaboration with external raw material suppliers.

The Cooper Companies - COO Debts to Book Capitalization (period 07/04/2022 - 10/27/2026)
Brand item of CooperSurgical

Steady demand for The Cooper Companies (COO) vision care products allows the company to effectively manage its leverage. By analyzing the chart of debt-to-capital ratio, an investor assesses the ratio of total debt to the sum of equity and debt, which determines the financial stability and the degree of the business's dependence on external financing while maintaining growth rates.

Competitors of The Cooper Companies

Boston Scientific - Debts to Book Capitalization|Debt to Book Value edwards.com EW|Debts to Book Capitalization RMD (ResMed)|PODD - Debts to Net Assets|ZBH: Debts to Book Capitalization|ALGN (Align Corp) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Globus Medical, Inc.|Debt to Book Capitalization Ratio TransMedics Corp|ATEC (Alphatec) - Debts to Book Capitalization|Debts to Net Assets CryoLife AORT|DJO Global (ENOV) - Debt to Book Value|Debts to Book Capitalization Ratio Integra LifeSciences Inc. IART|ESTA (Establishment Labs) - Debts to Book Capitalization|BBNX - Debts to Book Value|Debts to Book Capitalization IRADIMED|Debt to Book Value Ratio Embecta Corp|TNDM - Debt to Book Value|Debt to Net Assets Ratio AXGN|Debt to Book Capitalization Ratio SIBN (SI-BONE, Inc.)|Debt to Book Value orthofix.com (OFIX)|BVS: Debts to Book Capitalization|Debts to Book Value OrthoPediatrics Corp KIDS|Treace Medical (TMCI) - Debts to Book Capitalization|SRTA - Debt to Book Value Ratio|Carlsmed Inc - Debts to Book Capitalization|rxsight.com (RXST) - Debts to Net Assets|Debts to Book Capitalization CLPT|Debt to Book Value Stereotaxis Inc|Debts to Book Capitalization STIM|Debts to Book Capitalization SGHT (Sight Sciences Inc)|Debt to Book Capitalization Ratio Orchestra BioMed, Inc. OBIO|ANIK - Debt to Book Capitalization Ratio|Debt to Book Value InspireMD (NSPR)|ZJYL - Debt to Net Assets Ratio|Debts to Book Capitalization VANI|XTNT (Xtant Medical) - Debts to Book Value|NeuroOne Medical Technologies - Debt to Book Capitalization Ratio|Debt to Net Assets Modular Med (MODD)|Debt to Book Value MYO|Debts to Book Capitalization Envoy Medical Inc. (COCH)|Debts to Book Capitalization VVOS|enVVeno Corp - Debts to Net Assets|Debt to Book Capitalization Ratio SINTX Technologies|TNON: Debts to Book Capitalization Ratio|LFWD (Lifeward) - Debt to Book Capitalization Ratio|Autonomix Medical (AMIX) - Debt to Book Value|Debts to Book Capitalization IVF (INVO Bioscience, Inc.)|Debts to Book Value BBLG|Debt to Book Capitalization Ratio Axonics, Inc. AXNX|Debt to Book Value Ratio biolase.com BIOL|Debt to Book Value Dynatronics (DYNT)|FNA - Debt to Book Capital|Debt to Book Value INVO Bio INVO